NRX Pharmaceuticals, Inc. Share Price
NRXPNRX Pharmaceuticals, Inc. Stock Performance
Open $2.42 | Prev. Close $2.43 | Circuit Range N/A |
Day Range $2.40 - $2.50 | Year Range $1.15 - $6.01 | Volume 8,935 |
Average Traded $2.46 |
NRX Pharmaceuticals, Inc. Share Price Chart
About NRX Pharmaceuticals, Inc.
NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder, and chronic pain. Its lead drug candidates include NRX-101, an oral, fixed dosed combination of D-cycloserine and lurasidone for suicidal treatment-resistant bipolar depression in patients with sub-acute suicidal ideation and behavior in phase 2 trial; and NRX-100, a preservative-free formulation of ketamine for intravenous infusion and for the treatment of suicidal depression. The company has a license agreement with Alvogen, Inc. and Lotus Pharmaceutical Co. Ltd.; Apkarian Technologies; development and license agreement with Glytech, LLC; and Sarah Herzog Memorial Hospital. NRx Pharmaceuticals, Inc. was founded in 2015 and is based in Wilmington, Delaware.
NRX Pharmaceuticals, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
04-Dec-25 | $2.42 | $2.44 | +0.00% |
04-Dec-25 | $2.42 | $2.44 | +1.46% |
03-Dec-25 | $2.25 | $2.40 | +5.95% |
02-Dec-25 | $2.40 | $2.27 | -5.42% |
01-Dec-25 | $2.42 | $2.40 | -1.64% |
28-Nov-25 | $2.45 | $2.44 | +4.27% |
26-Nov-25 | $2.21 | $2.34 | +8.33% |